Data / Form D filings / Response Pharmaceuticals, Inc.
Response Pharmaceuticals, Inc.: Form D filings
Response Pharmaceuticals, Inc., a pharmaceuticals company in Falls Church, VA, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on June 28, 2024, reports $3.9 million sold of a $5 million offering to 51 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1104 WEST BROAD STREET #1064, Falls Church, VA, 22046
- Phone
- (703) 624-2024
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1913970
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 28, 2024 | New notice | $5,000,000 | $3,898,385 | $1,101,615 | 51 | Jun 13, 2024 | sec.gov |
| Dec 5, 2022 | Amendment | $8,000,000 | $7,988,250 | $11,750 | 127 | Feb 8, 2022 | sec.gov |
| Mar 1, 2022 | New notice | $6,000,000 | $3,225,000 | $2,775,000 | 47 | Feb 8, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Berendt | Director | |
| Donald Olds | Director | |
| Eric Keller | Executive Officer, Director |
Other pharmaceuticals companies in Virginia that filed recently
- Quoin Pharmaceuticals Ltd. $50 million · Sep 10, 2026
Every Form D from the week of Jun 24, 2024 · All recent filings in Virginia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Response Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.